Barclays’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8K | Sell |
2,001
-60,302
| -97% | -$241K | ﹤0.01% | 4168 |
|
|
2025
Q1 | $56K | Sell |
62,303
-29,331
| -32% | -$26.4K | ﹤0.01% | 3865 |
|
|
2024
Q4 | $254K | Buy |
91,634
+14,904
| +19% | +$41.3K | ﹤0.01% | 3405 |
|
|
2024
Q3 | $401K | Buy |
76,730
+55,497
| +261% | +$290K | ﹤0.01% | 3113 |
|
|
2024
Q2 | $94K | Sell |
21,233
-15,676
| -42% | -$69.4K | ﹤0.01% | 3406 |
|
|
2024
Q1 | $282K | Sell |
36,909
-32,215
| -47% | -$246K | ﹤0.01% | 3153 |
|
|
2023
Q4 | $295K | Buy |
69,124
+59,904
| +650% | +$256K | ﹤0.01% | 3317 |
|
|
2023
Q3 | $39K | Sell |
9,220
-985
| -10% | -$4.17K | ﹤0.01% | 3692 |
|
|
2023
Q2 | $56K | Buy |
10,205
+3,932
| +63% | +$21.6K | ﹤0.01% | 3627 |
|
|
2023
Q1 | $36K | Hold |
6,273
| – | – | ﹤0.01% | 3860 |
|
|
2022
Q4 | $7K | Sell |
6,273
-130
| -2% | -$145 | ﹤0.01% | 4174 |
|
|
2022
Q3 | $17K | Hold |
6,403
| – | – | ﹤0.01% | 3994 |
|
|
2022
Q2 | $31K | Sell |
6,403
-2,337
| -27% | -$11.3K | ﹤0.01% | 3923 |
|
|
2022
Q1 | $36K | Buy |
+8,740
| New | +$36K | ﹤0.01% | 4126 |
|